Terms: = Ovarian cancer AND MYC, c-Myc, 4609, ENSG00000136997
593 results:
1. Effect of myc and PARP Inhibitors in ovarian cancer Using an
Morea A; Saravi S; Sisu C; Hall M; Tosi S; Karteris E; Storlazzi CT
Anticancer Res; 2024 May; 44(5):1817-1827. PubMed ID: 38677725
[TBL] [Abstract] [Full Text] [Related]
2. Comprehensive Analysis of Clinically Relevant Copy Number Alterations (CNAs) Using a 523-Gene Next-Generation Sequencing Panel and NxClinical Software in Solid Tumors.
Gupta V; Vashisht V; Vashisht A; Mondal AK; Alptekin A; Singh H; Kolhe R
Genes (Basel); 2024 Mar; 15(4):. PubMed ID: 38674331
[TBL] [Abstract] [Full Text] [Related]
3. Interleukin 33 supports squamous cell carcinoma growth via a dual effect on tumour proliferation, migration and invasion, and T cell activation.
Perri G; Vilas Boas VG; Nogueira MRS; Mello Júnior EJF; Coelho AL; Posadas EM; Hogaboam C; Cavassani KA; Campanelli AP
Cancer Immunol Immunother; 2024 Apr; 73(6):110. PubMed ID: 38662248
[TBL] [Abstract] [Full Text] [Related]
4. Complexity of the Genetic Background of Oncogenesis in ovarian cancer-Genetic Instability and Clinical Implications.
Murawski M; Jagodziński A; Bielawska-Pohl A; Klimczak A
Cells; 2024 Feb; 13(4):. PubMed ID: 38391958
[TBL] [Abstract] [Full Text] [Related]
5. Locus-specific LINE-1 expression in clinical ovarian cancer specimens at the single-cell level.
Perkiö A; Pradhan B; Genc F; Pirttikoski A; Pikkusaari S; Erkan EP; Falco MM; Huhtinen K; Narva S; Hynninen J; Kauppi L; Vähärautio A
Sci Rep; 2024 Feb; 14(1):4322. PubMed ID: 38383551
[TBL] [Abstract] [Full Text] [Related]
6. Elongation factor 1A1 regulates metabolic substrate preference in mammalian cells.
Wilson RB; Kozlov AM; Hatam Tehrani H; Twumasi-Ankrah JS; Chen YJ; Borrelli MJ; Sawyez CG; Maini S; Shepherd TG; Cumming RC; Betts DH; Borradaile NM
J Biol Chem; 2024 Mar; 300(3):105684. PubMed ID: 38272231
[TBL] [Abstract] [Full Text] [Related]
7. LINC00629, a HOXB4-downregulated long noncoding RNA, inhibits glycolysis and ovarian cancer progression by destabilizing c-myc.
Liu J; Zhu Y; Wang H; Han C; Wang Y; Tang R
Cancer Sci; 2024 Mar; 115(3):804-819. PubMed ID: 38182548
[TBL] [Abstract] [Full Text] [Related]
8. Aneuploidy Landscape in Precursors of ovarian cancer.
Wang Y; Douville C; Chien YW; Wang BG; Chen CL; Pinto A; Smith SA; Drapkin R; Chui MH; Numan T; Vang R; Papadopoulos N; Wang TL; Shih IM
Clin Cancer Res; 2024 Feb; 30(3):600-615. PubMed ID: 38048050
[TBL] [Abstract] [Full Text] [Related]
9. Serial Circulating Tumor DNA Analysis with a Tumor-Naïve Next-Generation Sequencing Panel Detects Minimal Residual Disease and Predicts Outcome in ovarian cancer.
Heo J; Kim YN; Shin S; Lee K; Lee JH; Lee YJ; Choi Z; Park J; Min S; Kim SW; Choi JR; Kim S; Lee ST; Lee JY
Cancer Res; 2024 Feb; 84(3):468-478. PubMed ID: 38038965
[TBL] [Abstract] [Full Text] [Related]
10. Epigallocatechin gallate inhibits ovarian cancer cell growth and induces cell apoptosis via activation of FOXO3A.
Zhang Z; Zhang Q; Yu Y; Su S
In Vitro Cell Dev Biol Anim; 2023 Dec; 59(10):739-746. PubMed ID: 38038884
[TBL] [Abstract] [Full Text] [Related]
11. NMR-identification of the interaction between BRCA1 and the intrinsically disordered monomer of the myc-associated factor X.
Epasto LM; Pötzl C; Peterlik H; Khalil M; Saint-Pierre C; Gasparutto D; Sicoli G; Kurzbach D
Protein Sci; 2024 Jan; 33(1):e4849. PubMed ID: 38037490
[TBL] [Abstract] [Full Text] [Related]
12. Analysis of the Polymorphisms and Expression Levels of the BCL2, BAX and c-myc Genes in Patients with ovarian cancer.
Olbromski PJ; Bogacz A; Bukowska M; Kamiński A; Moszyński R; Pawlik P; Szeliga A; Kotrych K; Czerny B
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003498
[TBL] [Abstract] [Full Text] [Related]
13. Genomic and Molecular Characteristics of ovarian Carcinosarcoma.
Ramphal K; Hadfield MJ; Bandera CM; Hart J; Dizon DS
Am J Clin Oncol; 2023 Dec; 46(12):572-576. PubMed ID: 37986208
[TBL] [Abstract] [Full Text] [Related]
14. CUDC-907 exhibits potent antitumor effects against ovarian cancer through multiple in vivo and in vitro mechanisms.
Wang Y; Wen J; Sun X; Sun Y; Liu Y; Cheng X; Wu W; Liu Q; Ren F
Cancer Chemother Pharmacol; 2024 Apr; 93(4):295-306. PubMed ID: 37938423
[TBL] [Abstract] [Full Text] [Related]
15. A small-molecule inhibitor of TopBP1 exerts anti-myc activity and synergy with PARP inhibitors.
Lin FT; Liu K; Garan LAW; Folly-Kossi H; Song Y; Lin SJ; Lin WC
Proc Natl Acad Sci U S A; 2023 Oct; 120(44):e2307793120. PubMed ID: 37878724
[TBL] [Abstract] [Full Text] [Related]
16. Comparative study on the mutation spectrum of L-myc and C-myc genes of blood cfDNA in patients with ovarian cancer and healthy females.
Shabir S; Asiaf A
J Obstet Gynaecol Res; 2023 Dec; 49(12):2894-2904. PubMed ID: 37827180
[TBL] [Abstract] [Full Text] [Related]
17. Targeting RAS-ERK pathway alterations with MEK inhibitors to improve chemosensitivity in high grade serous ovarian cancers.
Nguyen NT; Raetz A; Montoya D; Schilling V; Tong C; Brooks RA; Leiserowitz G; Chien J
Gynecol Oncol; 2023 Nov; 178():69-79. PubMed ID: 37806229
[TBL] [Abstract] [Full Text] [Related]
18. N-myc Downstream Regulated Gene-1 May Play an Important Role in the Prognosis of ovarian cancer, in Its Association with Beta-Catenin.
Terada A; Tsuda N; Tasaki S; Park J; Nasu H; Tasaki K; Katsuda T; Nishio S; Yamaguchi T; Sanada S; Akiba J; Kuwano M; Ono M; Ushijima K
Kurume Med J; 2023 Nov; 69(1.2):39-46. PubMed ID: 37793886
[TBL] [Abstract] [Full Text] [Related]
19. Expression of DKK1 in Endometrial Endometrioid Carcinoma and Its Correlation with Wnt/β-catenin Signalling Pathway.
Das A; Mathur SR; Kumar S; Bhatla N
Sultan Qaboos Univ Med J; 2023 Aug; 23(3):303-310. PubMed ID: 37655078
[TBL] [Abstract] [Full Text] [Related]
20. myc is a clinically significant driver of mTOR inhibitor resistance in breast cancer.
Bhin J; Yemelyanenko J; Chao X; Klarenbeek S; Opdam M; Malka Y; Hoekman L; Kruger D; Bleijerveld O; Brambillasca CS; Sprengers J; Siteur B; Annunziato S; van Haren MJ; Martin NI; van de Ven M; Peters D; Agami R; Linn SC; Boven E; Altelaar M; Jonkers J; Zingg D; Wessels LFA
J Exp Med; 2023 Nov; 220(11):. PubMed ID: 37642941
[TBL] [Abstract] [Full Text] [Related]
[Next]
